26th Annual Event

6:30 p.m.  |  Cocktail Reception featuring the Learning Lounge

7:45 p.m.  |  Event Programming, Live Auction, Appeal, and Dinner Service

8:45 p.m.  |  Fireside Chat with Washington Commanders. Click Here to Meet Our Speakers

9:15 p.m.  |  After Party

Business Attire. Jacket required, tie optional. 

The new Lombardi Men’s Event Learning Lounge takes the place of the traditional Cancer Briefing, allowing guests to directly engage in intimate conversations with Georgetown Lombardi researchers.

Meet our inaugural participants: the doctors leading the future of minimally invasive and uniquely personalized cancer care at Georgetown Lombardi.

Dr. Chul Kim driving highly personalized cancer therapies through clinical trials. Be sure to visit the Learning Lounge to learn more!

Dr. Chul Kim is the Director of Thoracic Oncology at MedStar Georgetown University Hospital and an Associate Professor at Georgetown University. He specializes in thoracic oncology with a focus on developing and implementing innovative, personalized cancer therapies through clinical trials.

He earned his MD from Sungkyunkwan University School of Medicine, an MPH from Harvard, completed internal medicine training at the University of Minnesota, and a hematology-oncology fellowship at the NCI/NIH. Dr. Kim has received multiple honors, including the ASCO Conquer Cancer Norman Rales Young Investigator Award (2018) and the Georgetown Lombardi John F. Potter, MD Award (2021).

Dr. Kim has published over 90 peer-reviewed articles and is an active member of ASCO, IASLC, ITMIG.

Dr. Keith Kowalczyk is breaking ground in uniquely accurate robotic-assisted surgery. Be sure to visit the Learning Lounge to learn more!

Named to the Washingtonian Top Doctors Hall of Fame in 2026, Dr. Kowalczyk is board-certified in urology, with expertise in urologic oncology and robotic-assisted surgery in particular. He treats a full range of urologic conditions, but focuses on kidney, testicular, bladder, and prostate cancers. While skilled in performing traditional open surgery, his special expertise is in robotic-assisted surgery, and he has performed hundreds of procedures using this technology.

Dr. Kowalczyk is one of the few urologic surgeons in the D.C. metro area with specific expertise and training in urologic robotic surgery for urologic cancers, wherein the surgeon uses special instruments controlled through a robotic/computer console which allows increased range of motion and often more precision than traditional surgical instruments. The camera he uses provides 10 to 12 times more magnification than traditional cameras used in surgery.

Dr. Jonathan Lischalk is pioneering precision treatments without incision. Be sure to visit the Learning Lounge to learn more! 

Dr. Lischalk’s research focuses on genitourinary, thoracic (includes lung cancer), and central nervous system cancers. He is a subject matter expert in innovative approaches to prostate cancer treatment in particular, including MRI-directed SBRT microboost techniques and the integration of advanced technologies for precision treatment delivery (combination of radiology and genetic research). He delivered an oral presentation on the outcomes of some of this research in September 2025 at the annual ASTRO conference.

Building on discussions from recent conferences, there is substantial opportunity to explore toxicity parameters associated with micro-boosting in relation to genomic classifiers such as Decipher and emerging tools like ArteraAI.

Dr. Lischalk is a speaker and consultant for Accuray, Inc., a company devoted to expanding on the accuracy and precision of radiation therapy and cutting-edge treatment opportunities for patients.